| VP shunt | Ventriculo-Peritoneal shunt |
|---|---|
| VU shunt | Ventriculo-Ureteral shunt |
| SP | sacroposterior; sacrum to pubis; salivary progesterone; schizotypal personality; semi-private [room]... |
| HMPS | hexose monophosphate shunt |
| HMS | hexose monophosphate shunt; hypermobility syndrome |
| deoxycytidine monophosphate | <chemical> Deoxycytidine (dihydrogen phosphate). A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2'-,3'- or 5- positions. Chemical name: 5'-Cytidylic acid, 2'-deoxy- (12 Dec 1998) |
|---|---|
| dolichol monophosphate mannose | <chemical> A lipophilic glycosyl carrier of the monosaccharide mannose in the biosynthesis of oligosaccharide phospholipids and glycoproteins. Chemical name: beta-D-Mannopyranose, 1-ester with dolichol dihydrogen phosphate (12 Dec 1998) |
| inosine monophosphate | <chemical> Inosine 5'-monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. Chemical name: 5'-Inosinic acid (12 Dec 1998) |
| orotidine 5'-monophosphate | Orotidine 5'-monophosphate;an intermediate in the biosynthesis of the pyrimidine nucleosides (cytidine and uridine) that are found in nucleic acids. Synonym: orotidine 5'-monophosphate. (05 Mar 2000) |
| terpenyl monophosphate hydrolase | <enzyme> Hydrolyzes bornyl phosphate to borneol Registry number: EC 3.1.3.- (26 Jun 1999) |
| thiamine monophosphate | <chemical> Thiamine dihydrogen phosphate ester. The monophosphate ester of thiamine. Synonym: monophosphothiamine; vitamin b1 monophosphate. Chemical name: Thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(2-(phosphonooxy)ethyl)-, chloride (12 Dec 1998) |
| thymidine 5'-monophosphate | A major constituent of DNA. Synonym: thymidine 5'-monophosphate, thymine nucleotide. (05 Mar 2000) |
| thymidine monophosphate | <chemical> 5-thymidylic acid. A thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety. Chemical name: 5'-Thymidylic acid (12 Dec 1998) |
| uridine 5'-monophosphate | Uridine esterified by phosphoric acid on one or more sugar hydroxyl groups; UMP is typically uridine 5'-monophosphate; 2' and 3' derivatives also occur; precursor for the biosynthesis of other pyrimidine nucleotides. Synonym: UMP synthase, uridine 5'-monophosphate. Uridylic acid synthase, a bifunctional enzyme that contains the activities of both orotate phosphoribosyltransferase and orotidine-5'-monophosphate decarboxylase; catalyses a key step in pyrimidine biosynthesis; a deficiency of this enzyme leads to orotic aciduria. (05 Mar 2000) |
| uridine 5'-monophosphate synthase | <chemical> Consists of orotate phosphoribosyltransferase EC 2.4.2.10 and orotidylate decarboxylase EC 4.1.1.23 Chemical name: synthase, uridylate Synonym: ump synthase, uridine 5'-phosphate synthase, uridylate synthase (26 Jun 1999) |
| uridine monophosphate | <chemical> 5'-uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. Chemical name: 5'-Uridylic acid (12 Dec 1998) |
| uridine monophosphate kinase | <enzyme> Catalyses the phosphorylation of ump to udp; an aspect of EC 2.7.4.4 Registry number: EC 2.7.4.- Synonym: ump kinase, uridine-5-monophosphate kinase, uridylate kinase (26 Jun 1999) |
| 5-methyldeoxycytidine monophosphate aminohydrolase | <enzyme> Forms thymidylate; does not act on dcmp Registry number: EC 3.5.4.- Synonym: 5mdcmp aminohydrolase (26 Jun 1999) |
| 8-bromo cyclic adenosine monophosphate | <chemical> 8-bromoadenosine cyclic 3',5'-(hydrogen phosphate). A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase. Chemical name: Adenosine, 8-bromo-, cyclic 3',5'-(hydrogen phosphate) (12 Dec 1998) |
| arteriovenous shunt | <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis. Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues. (20 Jun 2000) |